In elderly primary essential hypertensive patients, administration of 5 mg/day of melatonin improved their antioxidant defense functions, as demonstrated by a significant increase in superoxide dismutase (SOD) 1 and catalase activities as well as a reduction in the serum malondialdehyde level [45]. Here, CAT is linked to essential hypertension.